Journal
CURRENT OPINION IN GENETICS & DEVELOPMENT
Volume 22, Issue 1, Pages 50-55Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.gde.2012.02.008
Keywords
-
Categories
Funding
- European Research Council (ERC)
- Fondo de Investigaciones Sanitarias [PI08-1345]
- MICINN
- [SAF2011-22803]
- ICREA Funding Source: Custom
Ask authors/readers for more resources
For many years cancer research has focused on genetic defects, but during the last decade epigenetic deregulation has been increasingly recognized as a hallmark of cancer. The advent of genome-scale analysis techniques, including the recently developed next-generation sequencing, has enabled an invaluable advance in the molecular mechanisms underlying tumor initiation, progression, and expansion. In this review we describe recent advances in the field of cancer epigenomics concerning DNA methylation, histone modifications, and miRNAs. In the near future, this information will be used to generate novel biomarkers of relevance to diagnosis, prognosis, and chemotherapeutic response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available